(R)-Darifenacin-d4 is a deuterated form of the medication Darifenacin, which is used to treat symptoms of an overactive bladder. The medication works by blocking the muscarinic receptors in the bladder, which helps to reduce involuntary contractions and increase the bladder's capacity.
Chemically, (R)-Darifenacin-d4 is a selective M3 muscarinic receptor antagonist. It has a molecular weight of 480.63 g/mol and a chemical formula of C28H26D4N3O2S. It is typically administered orally in tablet form, with a recommended dosage of 7.5mg once daily.
In terms of usage, (R)-Darifenacin-d4 is recommended for adults who experience symptoms of an overactive bladder, such as urinary urgency, frequency, and urge incontinence. It is not recommended for individuals who have urinary retention or gastric retention, as the medication can worsen these conditions.
There are some potential side effects associated with (R)-Darifenacin-d4, including dry mouth, constipation, blurred vision, and difficulty urinating. It is important for patients to discuss these potential side effects with their healthcare provider before starting the medication. Additionally, patients should inform their healthcare provider of any other medications they are taking, as certain medications can interact with (R)-Darifenacin-d4 and increase the risk of side effects.